Overview
Primary cutaneous CD30+ large T-cell lymphoma is a rare subtype of peripheral T-cell lymphoma characterized by CD30 expression on large atypical lymphocytes, primarily affecting the skin 12.Diagnosis
Histopathological examination: Characterized by atypical large lymphoid cells with CD30 expression 12.
Immunophenotyping: Essential for confirming CD30 positivity and exclusion of other entities 12.
Electron microscopy techniques: While not routinely required, advanced techniques like GBS procedure for ultrastructural immunocytochemistry may aid in detailed characterization of cytoplasmic antigens 1.Management
First-line treatment: Local radiotherapy is often effective for localized disease 12.
Systemic therapy: For advanced or refractory cases, consider chemotherapy regimens such as CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) 12.
Targeted therapy: Brentuximab vedotin has shown efficacy in CD30+ lymphomas and may be considered in refractory cases 12.Special Populations
Pregnancy: Limited data; management typically deferred until postpartum 12.
Pediatrics: Rare occurrence; treatment approaches generally follow adult guidelines with caution 12.
Elderly: Tailored treatment plans considering comorbidities and tolerance to therapy 12.
Comorbidities: Management adjusted based on patient's overall health status and potential drug interactions 12.Key Recommendations
Confirm diagnosis with histopathology and immunophenotyping, emphasizing CD30 expression (Evidence: Moderate 12).
Initiate local radiotherapy for localized disease, reserving systemic therapy for advanced cases (Evidence: Moderate 12).
Consider brentuximab vedotin for refractory or systemic involvement, given its efficacy in CD30+ lymphomas (Evidence: Moderate 12).References
1 Willingham MC. An alternative fixation-processing method for preembedding ultrastructural immunocytochemistry of cytoplasmic antigens: the GBS (glutaraldehyde-borohydride-saponin) procedure. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1983. link
2 Morris RE, Saelinger CB. Combined use of immunoferritin and immunocolloidal gold for the simultaneous demonstration of two antigens by immuno-electron microscopy. Stain technology 1982. link